Zelira Therapeutics Raises $1.77m through US-based investors
Zelira Therapeutics (ZLD) raises $1.77 million to progress its clinical trials
The funds were raised via a...
Zelira Therapeutics: Launches first product line, RAF FIVE
Zelira Therapeutics (ZLD) launches its first product line, RAF FIVE, through its dermatology subsidiary, Ilera Derm...
Zelira Therapeutics (ZLD) has launched its proprietary cannabinoid medicine, Zenivol, in Australia
The company has received approval from the Therapeutic Goods Administration’s (TGA)...
